Reducing CRS following epcoritamab in R/R FL: insights from an optimization cohort of EPCORE NHL-1

(2:6)

Q\u0026A: How Can I Reduce my Risk of Cytokine Release Syndrome (CRS)? - Blood Cancer OncTalk 2023

(3:5)

Longer-term follow-up of prophylactic tocilizumab for the reduction of CRS in the MajesTEC-1 trial

(2:8)

Strategies to minimize the occurrence of CRS and ICANS in patients treated with CAR-T therapy

(1:31)

Tocilizumab pre-treatment reduced cytokine release syndrome in RRMM pts receiving cevostamab.

(10:29)

Duvelisib reduces CRS whilst maintaining CAR-T function

(4:58)

Will the CRS Score Drop in 2025? Expert Breakdown of Express Entry Trends

(21:33)

Will CRS Score Decrease in 2025? Canada Express Entry | Canada PR

(14:59)

Improved Assessment of Severity and Novel Management Strategies to Alleviate the Burden of CRSwNP

(1:3:30)

CAR-T Toxicities: CRS and ICANS

(30:53)

How to Cut Skate Guards | CRS Cross

(3:3)

Managing CRS and neurotoxicities associated with CAR-T in ZUMA-3

(1:48)

Analysis of the CRS score's reduction probability in 2024 | MakeHomeCanada

(48)

How to Lower Inflammation cRP #shorts

(29)

MajesTEC-1: Longer Follow-up Teclistamab + Tocilizumab Prophylaxis for CRS in RR multiple myeloma

(4:30)

Management of cytokine release syndrome and neurotoxicity: an emerging need

(2:15)

Canada lowering CRS Score for Skilled WorkerPR: New Provincial Nominee Program Draw

(3:42)

Canada PR : Lower CRS, Faster Processing, Higher target! | IRCC

(2:41)

Surprise Express Entry Draw with Lower CRS score despite Strike

(5:39)

Prophylactic tocilizumab to mitigate CRS in patients with R/R myeloma receiving talquetamab

(1:41)